The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
RKIP: Much more than Raf Kinase inhibitory protein
Abstract
From its discovery as a phosphatidylethanolamine‐binding protein in bovine brain to its designation as a physiological inhibitor of Raf kinase protein, RKIP has emerged as a critical molecule for maintaining subdued, well‐orchestrated cellular responses to stimuli. The disruption of RKIP in a wide range of pathologies, including cancer, Alzheimer's disease, and pancreatitis, makes it an exciting target for individualized therapy and disease‐specific interventions. This review attempts to highlight recent advances in the RKIP field underscoring its potential role as a master modulator of many pivotal intracellular signaling cascades that control cellular growth, motility, apoptosis, genomic integrity, and therapeutic resistance. Specific biological and functional niches are highlighted to focus future research towards an enhanced understanding of the multiple roles of RKIP in health and disease. J. Cell. Physiol. 228: 1688–1702, 2013. © 2013 Wiley Periodicals, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Collectively, these findings underscore RKIP’s versatility as a multifunctional dynamic switch in cell signaling events.[49]”
From Protein Kinase A Phosphorylates a Conformationally High-energy State of Raf Kinase Inhibitory Protein (2025) · cites this paper as [49]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A gene atlas of the mouse and human protein-encoding transcriptomes
Su, A. I., Wiltshire, T., Batalov, S., Lapp, H., Ching, K. A., Block, D., Zhang, J., Soden, R., Hayakawa, M., Kreiman, G., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400782101 · Cited by 3,475
Widespread changes in protein synthesis induced by microRNAs
Selbach, M., Schwanhäusser, B., Thierfelder, N., Fang, Z., Khanin, R., & Rajewsky, N. (2008) · Nature · doi:10.1038/nature07228 · Cited by 3,429 · cited 2×
“Alternatively, the overexpression of mir-155 conferred the opposite effect on RKIP protein stability (Selbach et al., 2008; Schwanhausser et al., 2009; http://psilac.mdc-berlin.de).”
BackgroundThe Polycomb complex PRC2 and its mark in life
Margueron, R., & Reinberg, D. (2011) · Nature · doi:10.1038/nature09784 · Cited by 3,347
The polycomb group protein EZH2 is involved in progression of prostate cancer
Varambally, S., Dhanasekaran, S. M., Zhou, M., Barrette, T. R., Kumar-Sinha, C., Sanda, M. G., Ghosh, D., Pienta, K. J., Sewalt, R. G. A. B., Otte, A. P., et al. (2002) · Nature · doi:10.1038/nature01075 · Cited by 2,717
Kleer, C. G., Cao, Q., Varambally, S., Shen, R., Ota, I., Tomlins, S. A., Ghosh, D., Sewalt, R. G. A. B., Otte, A. P., Hayes, D. F., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1933744100 · Cited by 1,649
A quantitative atlas of mitotic phosphorylation
Dephoure, N., Zhou, C., Villén, J., Beausoleil, S. A., Bakalarski, C. E., Elledge, S. J., & Gygi, S. P. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805139105 · Cited by 1,608
Lujambio, A., & Lowe, S. W. (2012) · Nature · doi:10.1038/nature10888 · Cited by 1,084
Cdc42 regulates GSK-3β and adenomatous polyposis coli to control cell polarity
Etienne-Manneville, S., & Hall, A. (2003) · Nature · doi:10.1038/nature01423 · Cited by 835
Phosphorylation by p38 MAPK as an Alternative Pathway for GSK3β Inactivation
Thornton, T. M., Pedraza-Alva, G., Deng, B., Wood, C. D., Aronshtam, A., Clements, J. L., Sabio, G., Davis, R. J., Matthews, D. E., Doble, B., et al. (2008) · Science · doi:10.1126/science.1156037 · Cited by 484
Global analysis of cellular protein translation by pulsed SILAC
Schwanhäusser, B., Gossen, M., Dittmar, G., & Selbach, M. (2009) · PROTEOMICS · doi:10.1002/pmic.200800275 · Cited by 356
High Levels of Nrf2 Determine Chemoresistance in Type II Endometrial Cancer
Jiang, T., Chen, N., Zhao, F., Wang, X.-J., Kong, B., Zheng, W., & Zhang, D. D. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0713 · Cited by 286 · cited 1×
“It has been well-documented that NF-kB induces Snail expression at the transcriptional level (Julien et al., 2007; Wu and Bonavida, 2009).”
Background
Research works printed but not linked: 181
- 10.1016/S0962-8924(00)01880-8 · DOI · Paper page
- 10.1001/archsurg.1997.01430330057009 · DOI · Paper page
- 10.1158/1940-6207.CAPR-12-0009 · doi:10.1158/1940-6207.capr-12-0009
- 10.1002/jcp.23011 · doi:10.1002/jcp.23011
- 10.1002/(SICI)1098-2264(199904)24:4<306::AID-GCC3>3.0.CO;2-5 · DOI
- 10.1136/jcp.2005.033167 · DOI
- 10.1038/modpathol.3800564 · doi:10.1038/modpathol.3800564
- 10.1200/JCO.2006.07.5499 · doi:10.1200/jco.2006.07.5499
- 10.1136/jcp.2007.046987 · doi:10.1136/jcp.2007.046987
- 10.1158/0008-5472.CAN-10-3102 · DOI
- 10.1039/C0MB00208A · DOI
- 10.1371/journal.pone.0029532 · DOI
- 10.1523/JNEUROSCI.5650-11.2012 · DOI
- 10.1006/jmbi.2000.3619 · DOI · Paper page
- 10.1016/S0969-2126(98)00125-7 · DOI · Paper page
- 10.4049/jimmunol.179.8.5441 · DOI
- 10.1038/onc.2009.214 · DOI · Paper page
- 10.4161/cc.9.24.14229 · DOI
- 10.1016/S0168-9525(99)01971-X · DOI · Paper page
- 10.1038/sj.onc.1210860 · DOI · Paper page
- 10.1016/0167-4838(84)90221-8 · DOI · Paper page
- 10.1016/j.canlet.2010.08.012 · DOI
- 10.1007/s10585-012-9470-8 · doi:10.1007/s10585-012-9470-8
- 10.1242/dmm.007872 · DOI
- 10.1016/j.lfs.2005.01.033 · DOI
- 10.1111/j.1471-4159.1988.tb10594.x · DOI
- 10.1016/j.niox.2010.10.001 · DOI
- 10.1016/j.niox.2008.04.018 · DOI
- 10.1021/bi971286w · doi:10.1021/bi971286w
- 10.1038/35000025 · DOI · Paper page
- 10.1074/jbc.M313816200 · doi:10.1074/jbc.m313816200
- 10.1007/s12032-008-9147-y · doi:10.1007/s12032-008-9147-y
- 10.1002/jcp.22907 · DOI
- 10.1074/jbc.M210015200 · DOI · Paper page
- 10.1038/emboj.2008.294 · DOI · Paper page
- 10.1158/0008-5472.CAN-12-0402 · doi:10.1158/0008-5472.can-12-0402
- 10.1074/jbc.M112.363812 · DOI
- 10.1002/iub.1044 · DOI
- 10.1083/jcb.200201098 · DOI · Paper page
- 10.1016/j.cell.2011.09.019 · DOI · Paper page
- 10.1007/978-1-60761-795-2_31 · doi:10.1007/978-1-60761-795-2_31
- 10.1016/j.molcel.2006.07.015 · DOI
- 10.1016/j.yexcr.2006.01.018 · DOI
- 10.1007/s004410050064 · doi:10.1007/s004410050064
- 10.1093/jnci/95.12.878 · DOI · Paper page
- 10.1002/pros.20319 · DOI · Paper page
- 10.1186/1756-9966-31-30 · DOI
- 10.1007/s12253-011-9470-z · doi:10.1007/s12253-011-9470-z
- 10.1038/nrc3205 · DOI · Paper page
- 10.1002/pmic.200900722 · doi:10.1002/pmic.200900722
- 10.1074/jbc.M308533200 · doi:10.1074/jbc.m308533200
- 10.1038/cr.2008.43 · DOI · Paper page
- 10.1128/MCB.01271-08 · DOI · Paper page
- 10.1007/s10585‐012‐9533‐x · doi:10.1007/s10585-012-9533-x
- 10.3109/07357907.2012.732164 · doi:10.3109/07357907.2012.732164
- 10.1158/1078-0432.CCR-05-0283 · DOI · Paper page
- 10.1016/S0076-6879(05)07021-7 · DOI
- 10.1002/pmic.201100419 · DOI
- 10.1111/j.1530-0277.2008.00867.x · DOI
- 10.1159/000236595 · doi:10.1159/000236595
- 10.1128/MCB.00323-08 · DOI · Paper page
- 10.1002/elps.11501301201 · doi:10.1002/elps.11501301201
- 10.1038/jid.2008.30 · DOI
- 10.1021/jf2052515 · doi:10.1021/jf2052515
- 10.1016/j.bbrc.2012.07.025 · DOI
- 10.1186/1471-2407-11-259 · DOI
- 10.1038/sj.onc.1208349 · DOI · Paper page
- 10.1158/0008-5472.CAN-03-3500 · DOI · Paper page
- 10.1007/s13277-012-0317-3 · DOI
- 10.1038/sj.onc.1210546 · DOI · Paper page
- 10.1016/S1535-6108(03)00132-6 · DOI · Paper page
- 10.1038/nrc780 · DOI · Paper page
- 10.1016/j.canlet.2004.02.006 · doi:10.1016/j.canlet.2004.02.006
- 10.3892/ijo.2012.1686 · DOI
- 10.3109/00313025.2010.522172 · DOI
- 10.1016/j.molcel.2011.08.025 · DOI · Paper page
- 10.1007/s00428-011-1174-y · doi:10.1007/s00428-011-1174-y
- 10.1016/j.prp.2012.02.011 · DOI
- 10.1074/jbc.M112.367656 · DOI
- 10.1126/science.7761854 · DOI · Paper page
- 10.1038/ng.159 · DOI · Paper page
- 10.1016/j.ejphar.2009.10.011 · DOI · Paper page
- 10.1038/sj.onc.1204541 · DOI · Paper page
- Kurdistani SK, 2011, Histone modifications in cancer biology and prognosis, Prog Drug Res, 67, 91
- 10.1053/j.gastro.2006.07.012 · DOI · Paper page
- 10.1007/978-1-61779-055-3_3 · DOI
- 10.1158/1541-7786.MCR-08-0093 · doi:10.1158/1541-7786.mcr-08-0093
- 10.4161/cc.8.9.8684 · doi:10.4161/cc.8.9.8684
- 10.1038/35077241 · DOI · Paper page
- 10.1038/nature02158 · DOI · Paper page
- 10.1111/j.1478-3231.2009.01981.x · doi:10.1111/j.1478-3231.2009.01981.x
- 10.1111/j.1742-4658.2012.08602.x · DOI
- 10.1002/cncr.25799 · doi:10.1002/cncr.25799
- 10.1007/s00428-009-0821-z · DOI
- 10.1136/jclinpath-2011-200358 · doi:10.1136/jclinpath-2011-200358
- 10.1371/journal.pone.0030769 · doi:10.1371/journal.pone.0030769
- 10.1177/1947601911407323 · DOI · Paper page
- 10.4161/cc.20624 · DOI
- 10.1136/gut.2005.082859 · DOI
- 10.1309/5D7MM22DAVGDT1R8 · DOI
- 10.1111/j.1365-2990.1995.tb01026.x · DOI
- 10.1111/j.1365-2990.1996.tb00918.x · DOI
- 10.1016/0006-8993(95)01181-1 · DOI
- 10.1371/journal.pone.0037819 · DOI
- 10.2164/jandrol.107.002964 · doi:10.2164/jandrol.107.002964
- 10.1097/PAT.0b013e32835817e8 · doi:10.1097/pat.0b013e32835817e8
- 10.1016/j.tibs.2010.02.009 · DOI · Paper page
- 10.1002/pmic.200600068 · doi:10.1002/pmic.200600068
- 10.1074/jbc.M111.237560 · DOI
- 10.1038/nrc2622 · DOI · Paper page
- 10.1089/omi.2010.0096 · doi:10.1089/omi.2010.0096
- 10.1016/S0065-230X(04)91005-6 · DOI · Paper page
- 10.1158/0008-5472.CAN-07-5003 · DOI · Paper page
- 10.1038/sj.onc.1208435 · DOI
- 10.1016/j.febslet.2006.10.054 · DOI
- 10.1002/jcb.22097 · DOI
- 10.1042/bj3010235 · doi:10.1042/bj3010235
- 10.1089/omi.2012.0048 · DOI
- 10.1002/path.2440 · DOI · Paper page
- 10.1038/283139a0 · DOI · Paper page
- 10.1161/CIRCRESAHA.107.168336 · DOI
- 10.1002/arch.20300 · doi:10.1002/arch.20300
- 10.1111/j.1476-5381.2008.00085.x · DOI · Paper page
- 10.1158/0008-5472.CAN-11-3546 · DOI · Paper page
- 10.1016/j.dci.2009.06.010 · DOI
- 10.1016/j.bbamem.2006.09.019 · DOI · Paper page
- 10.1152/physrev.1981.61.2.296 · DOI · Paper page
- 10.1016/0303-7207(94)03447-2 · doi:10.1016/0303-7207(94)03447-2
- 10.1111/j.1432-1033.1987.tb13519.x · DOI
- 10.1093/protein/5.4.295 · doi:10.1093/protein/5.4.295
- 10.1158/0008-5472.CAN-03-3861 · DOI · Paper page
- Schuierer MM, 2006, Raf kinase inhibitor protein is downregulated in hepatocellular carcinoma, Oncol Rep, 16, 451
- 10.1007/BF00160411 · doi:10.1007/bf00160411
- 10.1007/BF01923352 · doi:10.1007/bf01923352
- 10.1083/jcb.145.4.837 · DOI · Paper page
- 10.1152/ajpcell.1996.271.3.C962 · DOI
- 10.1016/S0969-2126(98)00126-9 · DOI
- 10.1006/jmbi.2001.4784 · DOI
- 10.1038/nrc3125 · DOI · Paper page
- 10.1371/journal.pone.0006028 · doi:10.1371/journal.pone.0006028
- 10.1371/journal.pone.0010479 · DOI
- 10.1038/nrclinonc.2011.65 · DOI
- 10.1107/S090744490200522X · doi:10.1107/s090744490200522x
- 10.1158/1940-6207.CAPR-11-0318 · DOI
- 10.1158/1078-0432.CCR-09-3352 · DOI · Paper page
- 10.1007/s12094-012-0870-7 · doi:10.1007/s12094-012-0870-7
- 10.1002/hed.20430 · DOI
- 10.1007/s11010-009-0186-2 · doi:10.1007/s11010-009-0186-2
- 10.1016/j.febslet.2009.12.051 · DOI
- 10.1371/journal.pone.0036187 · DOI
- 10.1016/j.brainresbull.2006.11.010 · DOI
- 10.1097/01.ASN.0000115334.65095.9B · DOI
- 10.1038/sj.cr.7290258 · DOI
- 10.1074/jbc.M413929200 · DOI · Paper page
- 10.1158/0008-5472.CAN-09-2777 · DOI · Paper page
- 10.1016/j.jss.2012.03.031 · doi:10.1016/j.jss.2012.03.031
- 10.1046/j.0014-2956.2001.02528.x · doi:10.1046/j.0014-2956.2001.02528.x
- 10.1073/pnas.93.25.14960 · DOI · Paper page
- 10.1615/ForumImmunDisTher.v2.i2.110 · doi:10.1615/forumimmundisther.v2.i2.110
- Wang Y, 2009, [Relationship between raf kinase inhibitor protein and metastasis of ovarian carcinoma], Zhonghua Fu Chan Ke Za Zhi, 44, 522
- 10.1016/j.ijrobp.2008.04.072 · doi:10.1016/j.ijrobp.2008.04.072
- 10.1615/CritRevImmunol.v29.i3.40 · DOI
- Wu XH, 2011, [Expression of Raf kinase inhibitor protein and its significance in invasion and metastasis of hepatocellular carcinoma], Zhonghua Zhong Liu Za Zhi, 33, 358
- 10.1134/S0026893311060197 · doi:10.1134/s0026893311060197
- 10.1016/j.jhep.2010.05.019 · DOI
- 10.1016/S0301-0082(03)00034-0 · DOI · Paper page
- 10.1038/43686 · DOI · Paper page
- 10.1128/MCB.20.9.3079-3085.2000 · DOI · Paper page
- 10.1128/MCB.21.21.7207-7217.2001 · DOI · Paper page
- 10.1074/jbc.M413878200 · DOI · Paper page
- 10.1038/emboj.2011.312 · DOI · Paper page
- 10.4161/cc.8.9.8308 · DOI
- 10.1038/leu.2012.61 · DOI
- 10.1517/14728222.12.10.1275 · DOI
- 10.1002/prca.200780099 · doi:10.1002/prca.200780099
- 10.1159/000343323 · doi:10.1159/000343323
- 10.4149/neo_2013_026 · doi:10.4149/neo_2013_026
- 10.1016/j.chembiol.2005.07.007 · DOI
- 10.1158/1078-0432.CCR-07-1380 · DOI
- 10.1038/sj.bjc.6604729 · DOI
- 10.1002/path.2879 · DOI
Cited by
Enkavi, G., Javanainen, M., Kulig, W., Róg, T., & Vattulainen, I. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00538 · Cited by 289
Olivieri, C., Biancaniello, C., Manu, V. S., Walters, M. S., Masterson, L., Rosner, M. R., De Simone, A., & Veglia, G. (2025) · Journal of Molecular Biology · doi:10.1016/j.jmb.2025.169466 · Cited by 2
Metadata
- Authors
- Al‐Mulla, F., Bitar, M. S., Taqi, Z., & Yeung, K. C.
- Venue
- Journal of Cellular Physiology
- Publisher
- Wiley
- Published
- 2013-04-18
- Volume
- 228
- Issue
- 8
- Pages
- 1688-1702
- ISSN
- 0021-9541
- 1097-4652
- Cited by
- 100
- References
- 11
- Language
- en
- Funders
- Kuwait Foundation for The Advancement of Sciences (KFAS) (2012-130-201)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.